Sarissa Capital Management acquired a 6.22% ownership stake in biotechnology firm Ariad Pharmaceuticals.
Ariad Pharmaceuticals Inc
Breaking News
Sarissa Capital Management acquired a 6.22% ownership stake in biotechnology firm Ariad Pharmaceuticals.